粘多糖病Ⅱ型
外显子
遗传学
生物
粘多糖病
突变
基因
内含子
分子生物学
突变试验
硫酸酯酶
限制性酶
基因型
限制地点
剪接位点突变
限制摘要
医学
疾病
酶
选择性拼接
酶替代疗法
内科学
生物化学
出处
期刊:Yichuan
[Science Press]
日期:2007-01-01
卷期号:29 (01): 37-37
被引量:3
摘要
In the present study, through PCR amplification and direct sequencing of mutation "hotspots", we were able to identify two novel mutations in the human iduronate-2-sulfatase (IDS) gene in two patients from unrelated families with mucopolysaccharidosis type II(MPS II). The novel mutation IVS 6 -1g-->a affected the 3' splice acceptor site of intron 6, and was predicted to result in exon skipping. The novel mutation c.1587-1588 ins T involved a single base insertion be-tween nucleotides 1,587 and 1,588 in exon 9, and was predicted to result in frame shift and premature termination. The two novel mutations did not occur in 6 other unrelated MPS patients or in 100 alleles from normal individuals, indicating that they were not polymorphisms. The PCR-restriction enzyme digestion showed that the two newly identified mutations were of maternal origin, which was consistent with the X-linked recessive disorder. These findings suggest that the IDS gene mutations could be detected by amplifying mutation "hotspots", direct sequencing and restriction digestion analysis, and the newly identified mutations may be disease-causing.
科研通智能强力驱动
Strongly Powered by AbleSci AI